RSS feed

Publications by Marzena T. Szwed

34 publications found

Original articles

Szwed M, Michlewska S, Kania K, Szczęch M, Marczak A, Szczepanowicz K (2023)
New SDS-Based Polyelectrolyte Multicore Nanocarriers for Paclitaxel Delivery-Synthesis, Characterization, and Activity against Breast Cancer Cells
Cells, 12 (16)
DOI 10.3390/cells12162052, PubMed 37626862

Wawrowicz K, Majkowska-Pilip A, Szwed M, Żelechowska-Matysiak K, Chajduk E, Bilewicz A (2022)
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma
Int J Mol Sci, 23 (23)
DOI 10.3390/ijms232314773, PubMed 36499101

Bednarska-Szczepaniak K, Przelazły E, Kania KD, Szwed M, Litecká M, Grűner B, Leśnikowski ZJ (2021)
Interaction of Adenosine, Modified Using Carborane Clusters, with Ovarian Cancer Cells: A New Anticancer Approach against Chemoresistance
Cancers (Basel), 13 (15)
DOI 10.3390/cancers13153855, PubMed 34359756

Głowacki S, Synowiec E, Szwed M, Toma M, Skorski T, Śliwiński T (2021)
Relationship between Oxidative Stress and Imatinib Resistance in Model Chronic Myeloid Leukemia Cells
Biomolecules, 11 (4)
DOI 10.3390/biom11040610, PubMed 33924068

Wigner P, Zielinski K, Labieniec-Watala M, Marczak A, Szwed M (2021)
Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells
Sci Rep, 11 (1), 4544
DOI 10.1038/s41598-021-84146-4, PubMed 33633284

Wigner P, Zielinski K, Michlewska S, Danielska P, Marczak A, Ricci EJ, Santos-Oliveira R, Szwed M (2021)
Disturbance of cellular homeostasis as a molecular risk evaluation of human endothelial cells exposed to nanoparticles
Sci Rep, 11 (1), 3849
DOI 10.1038/s41598-021-83291-0, PubMed 33589697

Valsalakumari R, Yadava SK, Szwed M, Pandya AD, Mælandsmo GM, Torgersen ML, Iversen TG, Skotland T, Sandvig K, Giri J (2021)
Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells
Int J Pharm, 597, 120217
DOI 10.1016/j.ijpharm.2021.120217, PubMed 33486035

Jedrzejczyk M, Wisniewska K, Kania KD, Marczak A, Szwed M (2020)
Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells
Int J Mol Sci, 21 (24)
DOI 10.3390/ijms21249390, PubMed 33321722

Szwed M, Torgersen ML, Kumari RV, Yadava SK, Pust S, Iversen TG, Skotland T, Giri J, Sandvig K (2020)
Biological response and cytotoxicity induced by lipid nanocapsules
J Nanobiotechnology, 18 (1), 5
DOI 10.1186/s12951-019-0567-y, PubMed 31907052

Świderska E, Podolska M, Strycharz J, Szwed M, Abramczyk H, Brożek-Płuska B, Wróblewski A, Szemraj J, Majsterek I, Drzewoski J, Śliwińska A (2019)
Hyperglycemia Changes Expression of Key Adipogenesis Markers (C/EBPα and PPARᵞ)and Morphology of Differentiating Human Visceral Adipocytes
Nutrients, 11 (8)
DOI 10.3390/nu11081835, PubMed 31398873

Szwed M, Sønstevold T, Øverbye A, Engedal N, Grallert B, Mørch Ý, Sulheim E, Iversen TG, Skotland T, Sandvig K, Torgersen ML (2019)
Small variations in nanoparticle structure dictate differential cellular stress responses and mode of cell death
Nanotoxicology, 13 (6), 761-782
DOI 10.1080/17435390.2019.1576238, PubMed 30760074

Toma M, Witusik-Perkowska M, Szwed M, Stawski R, Szemraj J, Drzewiecka M, Nieborowska-Skorska M, Radek M, Kolasa P, Matlawska-Wasowska K, Sliwinski T, Skorski T (2018)
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
Oncotarget, 9 (96), 36867-36877
DOI 10.18632/oncotarget.26409, PubMed 30627327

Bielecka-Kowalska A, Czarny P, Wigner P, Synowiec E, Kowalski B, Szwed M, Krupa R, Toma M, Drzewiecka M, Majsterek I, Szemraj J, Sliwinski T, Kowalski M (2017)
Ethylene glycol dimethacrylate and diethylene glycol dimethacrylate exhibits cytotoxic and genotoxic effect on human gingival fibroblasts via induction of reactive oxygen species
Toxicol In Vitro, 47, 8-17
DOI 10.1016/j.tiv.2017.10.028, PubMed 29107684

Labieniec-Watala M, Szwed M, Hertel J, Wisnik E (2017)
Low Concentrations of Cationic PAMAM Dendrimers Affect Lymphocyte Respiration in In vitro Studies
Curr Pharm Biotechnol, 18 (2), 150-157
DOI 10.2174/1389201017666161229153018, PubMed 28034293

Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KR, Junqueira MS, Bernardes ES, da Silva EO, Tavares MI, Santos-Oliveira R (2016)
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals
Onco Targets Ther, 9, 5847-5854
DOI 10.2147/OTT.S110787, PubMed 27713638

Szwed M, Santos-Oliveira R (2016)
Nanoparticles with Therapeutic Properties Generate Various Response of Human Peripheral Blood Mononuclear Cells
J Nanosci Nanotechnol, 16 (6), 6545-50
DOI 10.1166/jnn.2016.12084, PubMed 27427750

Szwed M, Wrona D, Kania KD, Koceva-Chyla A, Marczak A (2015)
Doxorubicin-transferrin conjugate triggers pro-oxidative disorders in solid tumor cells
Toxicol In Vitro, 31, 60-71
DOI 10.1016/j.tiv.2015.11.009, PubMed 26607004

Szwed M, Laroche-Clary A, Robert J, Jozwiak Z (2015)
Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation
Cell Oncol (Dordr), 39 (2), 107-18
DOI 10.1007/s13402-015-0256-2, PubMed 26611752

Szwed M, Kania KD, Jozwiak Z (2015)
Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors
Int J Biochem Cell Biol, 70, 57-67
DOI 10.1016/j.biocel.2015.10.020, PubMed 26520467

Szwed M, Kania KD, Jozwiak Z (2015)
Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells
Leuk Res, 39 (10), 1096-102
DOI 10.1016/j.leukres.2015.07.003, PubMed 26271413

Szwed M, Kania KD, Jozwiak Z (2014)
Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin
Cell Oncol (Dordr), 37 (6), 421-8
DOI 10.1007/s13402-014-0205-5, PubMed 25410120

Szwed M, Kania KD, Jozwiak Z (2014)
Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin-transferrin conjugate in human leukemia cell lines
Leuk Lymphoma, 56 (5), 1475-83
DOI 10.3109/10428194.2014.955022, PubMed 25166006

Szwed M, Kania KD, Jozwiak Z (2014)
Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate
Biochimie, 107 Pt B, 358-66
DOI 10.1016/j.biochi.2014.10.005, PubMed 25312849

Szwed M, Laroche-Clary A, Robert J, Jozwiak Z (2014)
Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines
Chem Biol Interact, 220, 140-8
DOI 10.1016/j.cbi.2014.06.013, PubMed 24998637

Szwed M, Jozwiak Z (2014)
Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells
Mutat Res Genet Toxicol Environ Mutagen, 771, 53-63
DOI 10.1016/j.mrgentox.2014.06.007, PubMed 25308442

Rogalska A, Szwed M, Rychlik B (2014)
The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells
ScientificWorldJournal, 2014, 819548
DOI 10.1155/2014/819548, PubMed 24574923

Szwed M, Matusiak A, Laroche-Clary A, Robert J, Marszalek I, Jozwiak Z (2013)
Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells
Toxicol In Vitro, 28 (2), 187-97
DOI 10.1016/j.tiv.2013.09.013, PubMed 24055890

Rogalska A, Marczak A, Gajek A, Szwed M, Śliwińska A, Drzewoski J, Jóźwiak Z (2012)
Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
Toxicol In Vitro, 27 (1), 239-49
DOI 10.1016/j.tiv.2012.09.006, PubMed 22995584

Sliwinska A, Rogalska A, Szwed M, Kasznicki J, Jozwiak Z, Drzewoski J (2011)
Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells
Mol Biol Rep, 39 (5), 5253-67
DOI 10.1007/s11033-011-1323-z, PubMed 22183301

Rogalska A, Gajek A, Szwed M, Jóźwiak Z, Marczak A (2011)
The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin
Toxicol In Vitro, 25 (8), 1712-20
DOI 10.1016/j.tiv.2011.08.009, PubMed 21896327

Kopka A, Janiszewska S, Szwed M, Duda W, Bukowska B (2011)
The effect of alendronate sodium on human erythrocytes
Environ Toxicol Pharmacol, 32 (2), 306-14
DOI 10.1016/j.etap.2011.07.004, PubMed 21843812

Rogalska A, Szwed M, Jóźwiak Z (2010)
Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours
Mutat Res, 700 (1-2), 1-10
DOI 10.1016/j.mrgentox.2010.04.013, PubMed 20399885

Review articles

Szwed M, Marczak A (2024)
Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment-The Current State of Knowledge
Cancers (Basel), 16 (6)
DOI 10.3390/cancers16061156, PubMed 38539491

Szwed M (2014)
[Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis]
Postepy Hig Med Dosw (Online), 68, 198-208
DOI 10.5604/17322693.1091102, PubMed 24662788